1Li WW, Jaffe M, Li VW, et al. Lessons to be learned from clinical trials of angiogenesis modulators in ischemic diseases.In: Rubanyi GM, ed. Angiogenesis in health and disease: ba-sic mechanisms and clinical application. New York, NY:I)ekker, 2000, 519 - 536.
2Libuttti SK, Choyke P, Carrasquillo JA, et al. Monitoring responses to antiangiogenic agents using noninvasive imaging tests. Cancer J Sci Am, 1999, 5(5) : 252- 256.
3Cenic A, Nabavi DG, Craen RA, et al. ACT method to measure hemodynamics in brain tumors: validation and application to cerebral blood flow maps. AJNR, 2000, 21(3) :462 - 470.
4Purdie TG, Henderson E, Lee TY. Thymidine phosphorylaseas a target for imaging and therapy with thymineanalogs.Cancer Chemother Pharmacol, 2001, 48(5) : 407 - 412.
5Hayashi K, Tozaki M, Sugisaki M, et al. Dynamic multislice helical CT of ameloblastoma and odontogenic keratoeyst: correlation between contrast enhancement and angiogenesis.J Comput Assist Tomogr, 2002, 26(6) : 922 - 926.
6Tateishi U, Kusumoto M, Nishihara H, et al. Contrast- enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer,2002, 95 (4) : 835 - 842.
7Neernan M, Dafni H, Bukhari O, et al. In vivo BOLD contrastMRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med,2001,45(5) :887 - 898.
8Turetschek K, Roberts TP, Floyd E, et al. Tumour microvascular characterization using ultrasmall superparamagnetic iron oxide particles(USPIO) in an experimental breast cancermodel. J Magn Reson Imaging, 2001, 13(6):882-888.
9Yamada I, Aung W, Himeno Y, et al. Diffusion coefficients in abdominal organs and hepetic lesion: evaluation with intravoxel incoherent motion echo - planar MR imaging. Radiology, 1999, 210(3) : 617- 623.
10Strohmeyer D, Frauscher F, Klauser A, et al. Contrast - enhanced transrectal color doppler ultrasonography (TRCDUS)for assessment of angiogenesis in prostate cancer. Antieancer Res, 2001, 21(4B) : 2907 - 2913.
2[1]Mise K,Tashiro S,Yogita S,et al.Assessment of the biological malignancy of hepatocellular carcinoma:relationship to clinico-pathological factors and prognosis[J].Clin Cancer Res,1998,4(6):1475
3[4]Nakae S,Nakamura T,Ikegawa R,et al.Evaluation of argyrophilie nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer[J].J Surg Oncol,1998,69(1):28.
